Development of the new synthetic triterpenoid cddo-2P-IM (TTX01) for glioblastoma
Ended Project Grant Awarded Last action
- Award ID
- R43CA254786
- Recipient
-
Triterpenoid Therapeutics Inc. UEI JA25GYTMYJP3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $399,908
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- New Hampshire, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $399,908 |
Quick answers
Who received award R43CA254786?
R43CA254786 was awarded to Triterpenoid Therapeutics Inc. by National Cancer Institute (National Institutes of Health) on September 8, 2020.
How much is award R43CA254786 worth?
$399,908 has been obligated on R43CA254786.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award